Acorah Software Products - Accounts Production 16.4.660 false true 31 July 2023 1 August 2022 false true No description of principal activity 1 August 2023 31 July 2024 31 July 2024 14210092 Mr Michael Dean Baldwin iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14210092 2023-07-31 14210092 2024-07-31 14210092 2023-08-01 2024-07-31 14210092 frs-core:CurrentFinancialInstruments 2024-07-31 14210092 frs-bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 14210092 frs-bus:FilletedAccounts 2023-08-01 2024-07-31 14210092 frs-bus:Micro-entities 2023-08-01 2024-07-31 14210092 frs-bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 14210092 frs-bus:Director1 2023-08-01 2024-07-31 14210092 2022-07-31 14210092 2023-07-31 14210092 2022-08-01 2023-07-31 14210092 frs-core:CurrentFinancialInstruments 2023-07-31
Registered number: 14210092
Medecanter Ltd
Unaudited Financial Statements
For The Year Ended 31 July 2024
Balance Sheet
Registered number: 14210092
2024 2023
£ £
Current assets 557 288
Creditors: Amounts Falling Due Within One Year (16 ) (55 )
NET CURRENT ASSETS 541 233
TOTAL ASSETS LESS CURRENT LIABILITIES 541 233
Accruals and deferred income (238 ) -
NET ASSETS 303 233
CAPITAL AND RESERVES 303 233

Notes

1. General Information
Medecanter Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14210092 . The registered office is 94 Grange Road, Ashton-In-Makerfield, Wigan, WN4 0AY.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors on 10 July 2025 and were signed on its behalf by:
Mr Michael Dean Baldwin
Director
10/07/2025